We are live on ! Find out more

Palisade Bio

PALI

Market cap $342M

7 hedge funds and large institutions have $57.1M invested in Palisade Bio in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New

Increased

Maintained

Reduced

Closed

31% more call options, than puts

Call options by funds: $893K | Put options by funds: $681K

17% more funds holding

Funds holding: 6 → 7 (+1)

0% more ownership

Funds ownership: 0% → 0% (+0%)

17% less capital invested

Capital invested by funds: $68.5M → $57.1M (-$11.5M)

Holders

Holders Change

Holders Change %

+16.67%

% of All Funds

0.2%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

–

Closed

–

Calls

$893K

Puts

$681K

Net Calls

+$212K

Net Calls Change

-$369K

Top Buyers

Rank	Fund	Capital Flow
1	Northern Trust Chicago, Illinois	+$4.03M
2	PI Putnam Investments Boston, Massachusetts	+$4.03M

Top Sellers

Rank	Fund	Capital Flow
1	Millennium Management New York	-$1.18M
2	SG Americas Securities New York	-$193K
3	CS Cannell & Spears New York	-$105K
4	SCM Stevens Capital Management Radnor, Pennsylvania	-$75K
5	Tudor Investment Corp Stamford, Connecticut	-$51K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	PI 1 Putnam Investments Boston, Massachusetts	$13.8M	+$4.03M	+1	+33%
2	2 Vanguard Group Malvern, Pennsylvania	$9.08M	–	–	–
3	BFA 3 BlackRock Fund Advisors San Francisco, California	$5.43M	–	–	–
4	FAM 4 Fred Alger Management New York	$4.61M	–	–	–
5	5 Northern Trust Chicago, Illinois	$2.61M	+$4.03M	+1	New
6	6 State Street Boston, Massachusetts	$2.46M	–	–	–
7	BIT 7 BlackRock Institutional Trust San Francisco, California	$2.26M	–	–	–
8	8 Geode Capital Management Boston, Massachusetts	$1.66M	–	–	–
9	CS 9 Credit Suisse Zurich, Switzerland	$1.42M	–	–	–
10	IGIM 10 I.G. Investment Management Winnipeg, Manitoba, Canada	$1.19M	–	–	–
11	11 Bank of New York Mellon New York	$1.09M	–	–	–
12	TCIM 12 TIAA CREF Investment Management New York	$839K	–	–	–
13	13 Fifth Third Bancorp Cincinnati, Ohio	$689K	–	–	–
14	BIM 14 BlackRock Investment Management Wilmington, Delaware	$660K	–	–	–
15	15 AQR Capital Management Greenwich, Connecticut	$615K	–	–	–
16	16 D.E. Shaw & Co New York	$513K	–	–	–
17	17 California Public Employees Retirement System Sacramento, California	$511K	–	–	–
18	18 Morgan Stanley New York	$492K	–	–	–
19	19 Goldman Sachs New York	$484K	–	–	–
20	TC 20 TFS Capital West Chester, Pennsylvania	$473K	–	–	–
21	BCM 21 Bridgeway Capital Management Houston, Texas	$426K	–	–	–
22	22 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$416K	–	–	–
23	23 Mackenzie Financial Toronto Ontario, Ontario, Canada	$414K	–	–	–
24	24 Susquehanna International Group Bala Cynwyd, Pennsylvania	$410K	–	–	–
25	25 LPL Financial San Diego, California	$394K	–	–	–

PALI Hedge Fund Activity: Q3 2014 in Review

7 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q3 2014, worth a combined $57.1M — down 17% from $68.5M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PALI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Northern Trust, opening a new position worth an estimated $4.03M. The largest seller was Millennium Management, cutting an estimated $1.18M.

7 institutional investors held Palisade Bio (PALI) as of Q3 2014, up from 6 in Q2 2014.
Funds reported $57.1M of Palisade Bio stock for Q3 2014, down 17% quarter-over-quarter.
1 fund opened new Palisade Bio positions in Q3 2014 and 0 closed out, a net change of +1 holder.
The largest Palisade Bio buyer in Q3 2014 was Northern Trust, an estimated $4.03M added.
The largest Palisade Bio seller in Q3 2014 was Millennium Management, an estimated $1.18M sold.

Based on aggregated 13F filings for Q3 2014.

Palisade Bio PALI Market cap $342M